Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Melatonin.

M Mor1, P V Plazzi, G Spadoni

  • 1Dipartimento Farmaceutico, Università degli Studi di Parma, viale delle Scienze, Parma, I-43100, Italy. mor@ipruniv.cce.unipr.it

Current Medicinal Chemistry
|April 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effectiveness of physiotherapy interventions for Pregnancy-Related lumbopelvic pain: A systematic review and meta-analysis of randomized controlled trials.

Brazilian journal of physical therapy·2026
Same author

Long COVID sexual dysfunction among both genders: Evaluation of a cohort of COVID-19 recoverees.

Infectious diseases now·2023
Same author

Steroid-converting enzymes in human adipose tissues and fat deposition with a focus on AKR1C enzymes.

European review for medical and pharmacological sciences·2021
Same author

Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature.

Scientific reports·2021
Same author

MT1 and MT2 melatonin receptors play opposite roles in brain cancer progression.

Journal of molecular medicine (Berlin, Germany)·2021
Same author

First Report of the Root-Knot Nematode Meloidogyne marylandi on Turfgrasses in Israel.

Plant disease·2019

Melatonin, a hormone regulating circadian rhythms, has potential therapeutic uses. Its actions involve membrane and nuclear receptors, and it protects against oxidative stress, making its medicinal chemistry a key research area.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Melatonin is the primary hormone from the pineal gland, produced with a nocturnal circadian rhythm.
  • It regulates rhythmic functions and processes photoperiodic information in vertebrates.
  • Melatonin's full role in human physiology and pathology is under investigation, but it shows therapeutic potential.

Purpose of the Study:

  • To review the medicinal chemistry of ligands targeting melatonin membrane receptors.
  • To focus on published models of binding interactions.
  • To re-evaluate active compounds using new biological tests and receptor data.

Main Methods:

  • Analysis of pharmacophore and 3D-QSAR models for melatonin receptor ligands.
  • Consideration of binding interaction models.

Related Experiment Videos

  • Integration of data from new conformationally constrained ligands and selective antagonists.

    • Main Results:

    • Multiple pharmacophore and 3D-QSAR models exist for melatonin receptor ligands.
    • Inconsistencies among models may be resolved by re-evaluating compounds with new biological data.
    • New ligands and antagonists provide insights into receptor subtype interactions.

    Conclusions:

    • Medicinal chemistry of melatonin receptor ligands is crucial for understanding its therapeutic potential.
    • Further research integrating new data can clarify existing models and guide drug design.
    • Selective ligands and antagonists are key to exploring melatonin receptor subtypes.